About Turtle Pharma
Turtle Pharma is a company based in Mumbai (India) founded in 2015. It operates as a B2B. Turtle Pharma offers products and services including Apremilast, Azelastine Hydrochloride, Bimatoprost, Canagliflozin, and Ciprofloxacin Base. Turtle Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website turtlepharma.com
- Legal Name Turtle Pharma Private Limited
- Date of Incorporation 13 Mar, 2015
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1.71 Cr
FY 2025 · -43% YoY
- Net Loss-₹0.39 Cr
FY 2025 · -23% margin
- EBITDA-₹0.30 Cr
FY 2025 · -18% margin
Associated legal entities of Turtle Pharma
Turtle Pharma operates through Turtle Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Turtle Pharma Private Limited CIN U74900MH2015PTC262688 | Active | 13 Mar 2015 | Mumbai, Maharashtra | ₹1.7 Cr | – | 3 | View details |
Board of directors of Turtle Pharma Private Limited (Turtle Pharma)
Turtle Pharma Private Limited is the primary company behind Turtle Pharma. The board of Turtle Pharma Private Limited currently have 3 directors; the longest-serving is Himani Vijay Hiran, appointed in 2015. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Himani Vijay Hiran DIN 05125975 | Director | 13 Mar 2015 | 11 yrs 6 mo | Turtle Pharma Private Limited |
| Payal Raj Shah DIN 08007494 | Director | 01 Dec 2017 | 8 yrs 10 mo | Turtle Pharma Private Limited |
| Tatva Vijay Hiran DIN 10344730 | Director | 07 Oct 2023 | 3 yrs | Turtle Pharma Private Limited |
Products & Services of Turtle Pharma
Turtle Pharma offers a comprehensive portfolio of products and services, including Apremilast, Azelastine Hydrochloride, Bimatoprost, Canagliflozin, and Ciprofloxacin Base.
Treats arthritis symptoms by reducing inflammation.
Relieves allergy symptoms through histamine blockade.
Lowers eye pressure to treat glaucoma conditions.
Manages diabetes by controlling blood sugar levels.
Fights bacterial infections in various applications.
Helps regulate glucose for diabetes management.
Targets bacterial infections in veterinary use.
Treats respiratory and urinary tract infections.
Controls blood sugar in type 2 diabetes patients.
Combats infections in eyes and respiratory systems.
Used for urinary tract and gastrointestinal infections.
Effective against various bacterial diseases.
Reduces fever and relieves mild pain symptoms.
Treats chronic angina by improving heart function.
Fights bacterial infections in animal health.
Manages pulmonary arterial hypertension effectively.
Financials of Turtle Pharma
Figures of Turtle Pharma Private Limited, the primary company behind Turtle Pharma, for FY 2025. Revenue was ₹1.71 Cr (-43% year on year). Net loss was -₹0.39 Cr (-23% margin). EBITDA was -₹0.30 Cr (-18% margin). Revenue has grown at a compounded annual rate of -21% over three years and -5% over five years.
- ₹1.71 CrRevenue · FY 2025 · -43% YoY
- -₹0.39 CrNet loss · -23% margin
- -₹0.30 CrEBITDA · -18% margin
- ₹0.01 CrPaid-up capital
- -21%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Turtle Pharma Private Limited are on its company page.
Detailed financial statements for Turtle Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Turtle Pharma
Turtle Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.7M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.0M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.9M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.2M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Turtle Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Turtle Pharma
10 companies that operate in the same segment as Turtle Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Turtle Pharma
Turtle Pharma was founded in 2015.
Turtle Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Turtle Pharma, Turtle Pharma Private Limited, reported revenue of ₹1.71 Cr for FY 2025, down 43% year on year.
Turtle Pharma Private Limited develops and delivers active pharmaceutical ingredients, ensuring compliance with international regulations. Headquartered in Mumbai, with a manufacturing plant near Vadodara in Gujarats Special Economic Zone, they produce APIs from grams to kilograms using advanced facilities like reactors and dryers. Their activities include handling various chemical reactions and providing documentation support, serving customers in the pharmaceutical industry.
Turtle Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Turtle Pharma offers Apremilast, Azelastine Hydrochloride, Bimatoprost, Canagliflozin, and 6 more products and services.
Turtle Pharma operates through Turtle Pharma Private Limited.
The legal entities of Turtle Pharma currently have 3 directors, including Tatva Vijay Hiran, Himani Vijay Hiran, Payal Raj Shah.